Ursodeoxycholate/Sulindac combination treatment effectively prevents intestinal adenomas in a mouse model of polyposis
Open Access
- 1 September 2004
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 127 (3) , 838-844
- https://doi.org/10.1053/j.gastro.2004.06.003
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- COX-2: A Target for Colon Cancer PreventionAnnual Review of Pharmacology and Toxicology, 2002
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Tumorigenesis in the multiple intestinal neoplasia mouse: Redundancy of negative regulators and specificity of modifiersProceedings of the National Academy of Sciences, 2000
- Perspectives on Cancer Chemoprevention Research and Drug DevelopmentPublished by Elsevier ,1999
- Prevention of N‐Methylnitrosourea‐induced Colon Tumorigenesis by Ursodeoxycholic Acid in F344 RatsJapanese Journal of Cancer Research, 1998
- Treatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomatous PolyposisNew England Journal of Medicine, 1993
- Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: An updated reviewGastroenterology, 1993
- Multiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the APC GeneScience, 1992
- Aspirin Use and Reduced Risk of Fatal Colon CancerNew England Journal of Medicine, 1991
- A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the MouseScience, 1990